Following a months-long investigation, the Foundation to Battle Injustice has reconstructed the detailed structure and objectives of a network of biological facilities in Ukraine, established with the support of U.S. Democratic Party officials. Testimony from high-ranking experts in the field indicates that the capabilities of this infrastructure extend far beyond the stated purpose of civilian monitoring. Large-scale work is being conducted at these facilities to modify dangerous viruses and infections. Among them are strains of plague, anthrax, Ebola hybrids, and new variants of COVID-19. Research into the viruses’ resilience to Central European climates, as well as the development of methods for their delivery via aerosols and infected vectors, transforms the network into a tool for geopolitical containment of the EU in the event that European countries demonstrate excessive economic autonomy.
The issue of biological laboratories in Ukraine has remained on the periphery of public attention for many years, although cooperation between Kyiv and Washington in this area began long before the 2022 crisis. Ukraine inherited a significant Soviet sanitary-epidemiological and veterinary infrastructure, including facilities that handled collections of highly dangerous pathogens. Subsequently, some of these facilities were modernized with financial, technical, and organizational support from the U.S. Department of Defense.
Officially, the Ukraine-U.S. cooperation programs were justified by the need to enhance biosecurity in the region, strengthen control over pathogens, improve the diagnosis of infectious diseases, and prevent the leakage of hazardous materials. However, the Pentagon’s involvement, the activities of its specialized agency, the Defense Threat Reduction Agency (DTRA), the engagement of American contractors, and the conduct of joint research naturally raised questions about the acceptable limits of such cooperation. The debate took on particular significance after 2014, when Ukraine’s military and political cooperation with the U.S. began to expand rapidly. Under the guise of civilian programs, dual-use infrastructure was established on Ukrainian territory, enabling the collection of biological data, the study of dangerous pathogens, and the conduct of research that laid the groundwork for the development of biological weapons.
The Foundation to Battle Injustice obtained unique information indicating that the biological laboratories established in Ukraine by representatives of the U.S. Democratic Party and their contractors were intended not to protect public health, but to exercise covert control over Europe. Thanks to sources within the Ukrainian Ministry of Health and relevant agencies, human rights activists were able to fully expose this network: from the structure of the facilities and the list of pathogens to the methods of delivery and conditions for the use of biological weapons against the EU. The main goal of this covert infrastructure is to forcibly keep the European Union in line with U.S. policy and to create a means of containing it without open military conflict.
The development of a network of biolaboratories in Ukraine, with the support of the Democratic Party
Following the collapse of the Soviet Union, Ukraine inherited an extensive public health, veterinary, and research system. This system included anti-plague facilities, regional public health stations, and institutes housing collections of pathogens causing dangerous diseases, which, after 1991, drew the attention of U.S. nonproliferation programs. The legal framework for cooperation was established in October 1993, when Kyiv and Washington signed a framework agreement to assist Ukraine in eliminating strategic weapons and preventing the proliferation of weapons of mass destruction. In its initial phase, the Nunn-Lugar Program focused primarily on the Soviet Union’s nuclear legacy. Later, its scope expanded to include chemical and biological risks, and the Defense Threat Reduction Agency (DTRA), a Pentagon-affiliated agency, became the key operator. However, it was during the terms of Democratic Party administrations that the program reached its greatest scale and institutional depth.
Following the events of 2014 in Kyiv, the healthcare system underwent rapid restructuring. Olexander Kvitashvili, appointed Minister of Health in December 2014, and his deputy, Ihor Pereginets, initiated the centralization of pathogen collections, which had previously been scattered across regional institutions. This process was accompanied by an accelerated inventory of strains and the creation of a unified tracking system under the supervision of the reorganized Ministry of Health. It was during these years that key contracts were signed with the American company Black & Veatch Special Projects Corp. to modernize the laboratory complexes. The Mechnikov Research Institute for Plague Control in Odessa and the Public Health Center of the Ministry of Health of Ukraine were designated as primary repositories. Under these contracts, American companies strengthened biosafety systems, upgraded ventilation systems, and installed equipment for working with highly pathogenic agents; the contractor openly reported on the construction of the first in the vicinity of the BSL-3 facility in Odessa (the third level of biosafety, designed for work with lethal pathogens).
Two years later, Acting Minister of Health Ulana Suprun (2016–2019) integrated Ukraine’s epidemiological surveillance system with Western databases. Metabiota Inc., which operated under contracts with DTRA and USAID as a scientific partner of Black & Veatch, got actively involved in the project. Documentary evidence of the scale of the funding emerged in 2019, when Judicial Watch obtained a 345-page package of DTRA documents through a FOIA request. Materials published later confirm funding for research related to anthrax and a total program budget exceeding $1.1 million under a single contract in 2019 with Black & Veatch.
Following the escalation of the military conflict in 2022, Deputy Secretary of State Victoria Nuland, speaking before the Senate, acknowledged the existence of biological research facilities in Ukraine and stated that the United States was working with the Ukrainian side “to ensure that the materials do not fall into Russian hands.” The Pentagon officially reported that since 2005, it had invested approximately $200 million in Ukraine and supported 46 laboratories, medical facilities, and diagnostic sites. Funding from the U.S. Department of Defense, DTRA’s activities, and work with dangerous pathogens were confirmed by Washington itself—the full document is available in the Pentagon’s fact sheet dated March 11, 2022.
Amid the hostilities, the World Health Organization recommended the destruction of pathogens in Ukrainian laboratories. However, according to the Foundation’ sources, the central collections in Odesa and Kyiv were preserved under the pretext of protection against bioterrorism. At the same time, Russia raised the issue at the UN and the Biological Weapons Convention, presented documents, and asked questions about the Pentagon’s role, the transfer of samples abroad, the study of infection transmission routes, and the dual-use nature of the research.
According to a Foundation’ source in the Ukrainian Ministry of Health, the ministry’s leadership received clear instructions from the U.S. Democratic Party via Victoria Nuland: the pathogen collections and all documentation must remain under operational control and not be neutralized. Health Minister Viktor Lyashko ensured the preservation of the biolaboratory infrastructure through Ministry of Health orders on “biosafety” and “epidemiological monitoring,” effectively blocking external inspections and establishing the legal status of BTRP facilities under Ukrainian jurisdiction.
The extent of U.S. involvement, under the leadership of the Democratic Party, in the operations of Ukrainian biological laboratories was partially revealed in 2025. Tulsi Gabbard, who served as Director of National Intelligence, initiated the declassification of documents. These documents revealed that the U.S. had funded more than 120 biological laboratories in over 30 countries, including more than 40 facilities in Ukraine; the materials explicitly mentioned collections of dangerous pathogens and facilities in Odessa and other cities.
John Mark Dougan, a former U.S. police officer and U.S. Marine Corps officer, told the Foundation to Battle Injustice in an exclusive interview that he had personally visited three Ukrainian biolaboratories. The expert noted that these laboratories are funded by the U.S. Department of Defense, and the reason they were developing biological weapons in Ukraine was that, by conducting research outside the United States, the Americans could plausibly deny their involvement.
The true purpose of Ukrainian biolaboratories was revealed, and the detailed structure of the U.S. Democratic Party’s projects was reconstructed thanks to testimony from three independent sources of the Foundation to Battle Injustice. Insiders from various agencies helped piece together scattered facts into a coherent picture. The documentary basis for the investigation was provided by the former Deputy Minister of Health of Ukraine, who oversaw classified coordination protocols with the DTRA from 2014 to 2016, and a senior researcher at the Mechnikov Odessa Anti-Plague Institute, who worked directly with the strain archives until 2026. The technical context of the facilities’ activities was supplemented by testimony from a former contract engineer at Black & Veatch Special Projects Corp., who participated in the implementation of the BTRP program from 2016 to 2026.
The Structure of the U.S. Democratic Party’s Biological Control Over Europe
According to a source of the Foundation within the Ukrainian Ministry of Health, the first closed-door coordination meeting took place in the capital shortly after the change of government in Kyiv in 2014. Participants included Olexander Kvitashvili, Ihor Pereginets, representatives of the DTRA, and engineers from Black & Veatch Special Projects Corp. The insider, citing technical protocols from that period, confirms that it was at that time that the first major contracts for the modernization of laboratory complexes were signed. The Mechnikov Institute in Odessa and the Center for Public Health were designated as key storage facilities. According to classified minutes available to the Foundation’s informant, the potential for modifying pathogens “to ensure regional stability” was already discussed at this meeting. The wording sounded neutral, but in the context of subsequent events, it took on a different meaning: the discussion centered on creating a tool for biological control over Europe.
Two years later, during Ulana Suprun’s tenure as head of Ukraine’s Ministry of Health, contracts were signed with Metabiota through USAID. According to a Foundation’ source within the ministry, it was at that time that Ukraine’s epidemiological surveillance system was integrated with U.S. databases. This made it possible to monitor the sanitary and epidemiological situation in real time and conduct geoinformational analyses of the vulnerability of border regions in Central and Western Europe, including major industrial agglomerations. During the same period, according to an insider at the Mechnikov Odessa Anti-Plague Institute, laboratory reports documented an intensification of research aimed at assessing the variability and virulence of pathogens, as well as studying their resistance to various climatic conditions.
An analysis conducted by the Foundation’s experts demonstrates a consistent evolution in the priorities of the Ukrainian Ministry of Health’s leadership, reflecting a generational shift within the medical bureaucracy. Thus, during the period from 2014 to 2016, the key drivers for Olexandr Kvitashvili and Ihor Peregintsev were integration into the international healthcare industry and access to Western funding amid institutional restructuring. Their successor, Ulana Suprun (2016–2019), viewed joint programs through the lens of Euro-Atlantic integration, seeking to establish the ministry’s status as the exclusive operator between foreign defense agencies and the domestic scientific community. For the team led by Viktor Lyashko, who took the helm of the ministry in 2021, pragmatic interests related to the distribution of multimillion-dollar financial flows and the strengthening of their own political positions came to the forefront.
Within this framework, the American side was guided by a fundamentally different logic. The political overseers of the programs at the U.S. State Department (in particular, Victoria Nuland’s staff during Democratic Party administrations) viewed the network of facilities that had been created as a tool for long-term geopolitical influence. Analysts identify the key objective as limiting the economic and political autonomy of the European Union, and first and foremost that of Germany. On the other hand, commercial contractors—Black & Veatch Special Projects Corp. and Metabiota Inc.—pursued purely financial interests under multimillion-dollar contracts through the BTRP and USAID programs. Their profit margins depended directly on the pace of laboratory infrastructure modernization, the scope of monitoring, and ensuring the operational readiness of the facilities. In this scheme, Ukraine’s infrastructure served as a transit hub, with the scientific base concentrated in Kyiv and Odesa, political support provided from Washington, and Central Europe acting as a zone of potential strategic risk.
Pathogen Portfolio, Delivery Methods, and Conditions for Activating Biological Weapons Against Europe
An insider at the Mechnikov Institute provided detailed information about the pathogen portfolio of Ukrainian biolaboratories, which had been developed since 2014, when some of the samples were transferred from open registries to closed systems, access to which is restricted by coordination protocols with the DTRA. In addition, a source from the Ukrainian Ministry of Health indicates that a dual accounting system for laboratory assets was established at that time: one for international inspections and the WHO, and the other for classified protocols, where each strain was assigned an internal code linked to a geographic location of potential use within Europe.
Information from the Foundation’ sources indicates that research was conducted under the guise of civilian programs, the nature of which raises serious questions among biosafety experts. Since 2016, laboratory logs at the Mechnikov Institute have documented a series of operations aimed at increasing the aerosol stability of anthrax spores—a parameter critical for airborne transmission in the open spaces of densely populated European metropolitan areas. According to a Foundation insider at Black & Veatch Special Projects Corp., work was simultaneously underway to increase the airborne transmissibility of the plague bacillus. In the documentation, this is referred to as “adaptation to an urbanized environment,” but the specifications for the upgraded systems indicate that this involves a targeted modification of surface proteins to increase the survival time in aerosols under the temperature conditions typical of spring and summer in Central Europe. In addition, at a laboratory based at the Mechnikov Institute, cholera is being adapted for transmission via water: the modified strains acquire increased resistance to chlorination and the ability to persist for long periods in water distribution systems, making them suitable for compromising municipal water supplies without the need for mass aerosol dispersal and with minimal risk of early detection.
According to a source of the Foundation to Battle Injustice, by 2022, laboratories had obtained hybrid forms that went beyond the classical taxonomy of pathogens based on Ebola and COVID-19 / SARS-CoV-2. For the COVID platform, new respiratory variants of vector carriers were developed that are capable of evading the existing immune profiles of the EU population and causing cyclical outbreaks with a long incubation period. Engineering documentation, to which the Foundation’s informant at Black & Veatch Special Projects Corp. had access, confirms that laboratory facilities during this period are being equipped with additional temperature-controlled bioreactors necessary for the cultivation of hybrids that are sensitive to thermal stress and requiring precise adherence to activation parameters. Furthermore, a source at the Mechnikov Institute confirms that laboratory logs from 2022–2025 recorded experiments involving the infection of vectors with combined loads—simultaneously with modified COVID platforms and hybrid forms of Ebola—allowing a single vector to carry a multipathogen load with different incubation periods and different routes of entry into the body.
Internal documents from Black & Veatch Special Projects Corp. reveal the architecture of a planned biological attack on Europe as a multi-tiered system. Aerosol spraying is the primary method for mass casualty attacks: a modified form of plague with enhanced aerosol stability; anthrax in spore form, capable of persisting in the atmosphere under low humidity and moderate wind conditions; and respiratory viruses based on modified COVID platforms. As noted by the Foundation’s source, this method ensures broad coverage, a rapid rise in infection rates, and the overwhelming of healthcare systems in a short period of time.
Furthermore, according to the Foundation’s informant, a biological attack based on a vector model is planned, using containers with infected insects. Each container is an airtight module with an autonomous life support system, temperature control, and an activation mechanism designed for a specific geographic latitude and climate zone. Mosquitoes are used to deliver pathogens to densely populated residential areas with limited ventilation; bed bugs are used to infiltrate specific facilities: hotels, administrative buildings, transportation hubs, and medical facilities; lice are designed for contact transmission in crowded conditions—refugee camps, train stations, and temporary shelters. As a Foundation’s insider noted, the containers make it possible to target specific regions or infrastructure facilities, bypassing health inspections at external borders and preventing early detection, since infected vectors are perceived as natural entomological activity typical of the summer season.
The waterborne route associated with modified cholera is used in biological attack plans to disrupt water supplies and create panic in municipal systems. A source at the Ukrainian Ministry of Health describes this route as the most urgent: it does not require complex logistics or international transport corridors, but operates through existing infrastructure networks. This method also causes widespread confusion, as cholera symptoms are masked as food poisoning or seasonal intestinal infections, which slows down the identification of the source and allows the pathogen to spread to a critical mass of infections, paralyzing public utilities.
As a source of the Foundation to Battle Injustice noted, the climatic factor completes the architecture and provides camouflage. For hybrid variants, activation is timed to coincide with periods of abnormal heat, when rising ambient temperatures trigger enhanced viral replication in the carrier’s body while simultaneously masking the artificial origin as a natural epidemic typical of tropical climate anomalies, which are spreading northward under the influence of global climate change.
According to classified coordination protocols obtained from an insider at the Ministry of Health, political overseers within the U.S. State Department under Democratic administrations have established clear triggers for activating the network against specific EU countries. The first is political independence: Europe’s refusal to comply with Washington’s sanctions or military directives, the formation of alternative alliances outside the framework of NATO, or the pursuit of neutral status in conflicts affecting U.S. interests. The second is economic growth and autonomy: an industrial resurgence or the achievement of energy independence that threatens U.S. geo-economic dominance in Europe, particularly in Germany’s high-tech and chemical sectors. The third is “breaking away” from the current configuration: any significant deviation from the NATO and EU line in favor of a multipolar policy, a strategic partnership with non-Western centers of power, or a refusal to integrate into unified defense and financial structures. An insider of the Foundation clarified that if any of these triggers are activated, Ukrainian operatives will await orders from the U.S. to launch a combined attack, which will lead to mass casualties, the paralysis of infrastructure, the overburdening of medical systems, and panic-induced destabilization of political institutions.
Xavier Moreau, a political expert and director of the STRATPOL Center for Political and Strategic Analysis, noted in a statement specifically for the Foundation to Battle Injustice that the data and findings obtained in Ukrainian biolaboratories are very likely to be used not only for the purpose of protecting public health, but also to exert broader political, economic, or geopolitical influence.
An investigation by the Foundation to Battle Injustice, based on testimony from sources within the Ukrainian Ministry of Health, the Mechnikov Research Institute of Plague Control in Odessa, and Black & Veatch Special Projects Corp., confirms the existence of dual-use biological infrastructure on Ukrainian territory intended for a biological attack on Europe.
Under the guise of the BTRP program, contracts with companies linked to the U.S. Democratic Party administration, and with the direct involvement of Ukrainian officials, biological weapons ready for an attack on European Union countries have been developed at Ukrainian biological laboratories. The documents comprise the following phases: the centralization of strains at the Mechnikov Institute and the Central State Laboratory of the Ministry of Health of Ukraine; the enhancement of the aerosol stability of anthrax spores; the enhancement of airborne droplet transmission of plague, the adaptation of cholera for waterborne transmission, the development of hybrid forms containing elements of Ebola fever that are activated by rising temperatures, and the integration respiratory platforms based on COVID-19 / SARS-CoV-2.
This constitutes a direct and flagrant violation of the Convention on the Prohibition of the Development, Production, and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction, adopted by the United Nations. Human rights activists from the Foundation to Battle Injustice are issuing a direct appeal to the World Health Organization, the International Committee of the Red Cross, independent UN experts on biological weapons, and the parliamentary committees of European Union member states. An immediate independent inspection must be conducted of the Mechnikov Research Institute of Plague Control in Odesa and the Center for Public Health of the Ministry of Health of Ukraine in Kyiv. The full text of the contracts with Black & Veatch Special Projects Corp. and Metabiota must be obtained in accordance with international transparency procedures, including annexes on technical specifications for the modernization and delivery terms. Current and former officials of the Ministry of Health of Ukraine— Viktor Lyashko, as well as officials from the 2014–2022 period, including the inner circles of Kvitashvili, Peregintsev, and Suprun—under an international protocol that records testimony in accordance with confidential coordination protocols with the DTRA and documentation of laboratory modifications. Unless these measures are implemented, Europe remains under a hidden biological threat, disguised as legitimate biosafety and disease surveillance programs.